|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jul 01 '26 | Option Exercise | 2.76 | 3,333 | 9,199 | 99,745 | Jul 02 07:00 PM |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jul 01 '26 | Sale | 34.36 | 3,333 | 114,528 | 96,412 | Jul 02 07:00 PM |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jun 22 '26 | Option Exercise | 5.42 | 15,000 | 81,371 | 111,412 | Jun 24 07:24 PM |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Jun 22 '26 | Sale | 35.51 | 15,000 | 532,582 | 96,412 | Jun 24 07:24 PM |
| SEPN | DANIEL LONG | Officer | Jun 22 '26 | Proposed Sale | 36.17 | 25,000 | 904,250 | Jun 22 04:40 PM | |
| SEPN | Long Daniel D. | SVP, Drug Discovery | Nov 10 '25 | Sale | 18.06 | 3,501 | 63,223 | 92,911 | Nov 13 08:13 PM |
| SEPN | DANIEL DAVID LONG | Officer | Nov 10 '25 | Proposed Sale | 18.06 | 3,501 | 63,223 | Nov 10 04:07 PM | |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite